Breaking new ground in mitral valve interventions

Session comprising selected PCR London Valves 2024 Late-Breaking Trials submissions

Discussants: S. Kar, W. Wojakowski, J. Stehli, S. Worthley

Facilitators: T. Modine, F. De Brito Jr

Summary

What’s shaping the future of mitral valve therapies? This video from PCR London Valves 2024 unveils groundbreaking late-breaking trials that redefine the possibilities in mitral interventions.

You'll explore real-world insights from the OCEAN-Mitral registry on the MitraClip G4, uncover the link between tricuspid regurgitation and 3-year mortality after mitral valve treatment, delve into cutting-edge techniques like the Half Moon posterior leaflet augmentation, and much more! So, don't miss out—watch it now!

Presentations available when logged in:

Real-world outcomes with initial clip selection of MitraClip G4 device from OCEAN-Mitral registry
Tricuspid regurgitation and 3-year mortality after treatment of mitral valve disease
Half moon posterior leaflet augmentation: early human experience
HighLife transseptal mitral valve feasibility study: on-year outcomes of the first 45 patients
Left ventricular remodelling following transcatheter mitral valve replacement

Your free My PCR account will enable you to:

Become a PCR Companion
Access slide presentations from PCR Courses
Watch session videos and LIVE cases
Discuss cases with your peers
Submit and register for PCR Courses
Register for and view PCR Webinars
Read a selection of articles in EuroIntervention
And more…

Breaking new ground in mitral valve interventions

Session comprising selected PCR London Valves 2024 Late-Breaking Trials submissions

Log in or create account for free